Heterogeneous factors in dementia with Parkinson's disease: IMP-SPECT study

Parkinsonism and Related Disorders

Volumn 13, Issue 3, 2007, Pages 174-181

  Matsui, Hideaki ^a   Nishinaka, Kazuto ^a   Oda, Masaya ^a   Hara, Narihiro ^a   Komatsu, Kenichi ^a   Kubori, Tamotsu ^a   Udaka, Fukashi ^a  

^a SUMITOMO HOSPITAL   (Japan)

Author keywords

Alzheimer's disease; Dementia; Diffuse Lewy body disease; Frontal dysfunction; Parkinson's disease; Single photon emission computed tomography (SPECT)

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; ASSOCIATION CORTEX; BRAIN BLOOD FLOW; BRAIN CORTEX; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; FRONTAL CORTEX; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; DEMENTIA; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; INOSINE MONOPHOSPHATE; MALE; MENTAL STATUS SCHEDULE; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33947286323     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.10.005     Document Type: Article

References (68)

1. Mayeux R., Stern Y., Rosenstein R., Marder K., Hauser A., Cote L., et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol 45 (1988) 260-262
2. Cummings J.L. Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1 (1998) 24-36
3. Garron D.C., Klawans H.L., and Narin F. Intellectual functioning of persons with idiopathic Parkinsonism. J Nervous Mental Dis 154 (1972) 445-452
4. Hughes T.A., Ross H.F., Musa S., Bhattacherjee S., Nathan R.N., Mindham R.H., et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 54 (2000) 1596-1602
5. Rossor M.N. Parkinson's disease and Alzheimer's disease as disorders of the isodentritic core. BMJ 283 (1981) 1588-1590
6. Whitehouse P.J. The concept of subcortical and cortical dementia: another look. Ann Neurol 19 (1986) 1-6
7. Fazio F., and Messa G. Perfusion and metabolism in the dementias. A comparison between PET and SPECT. In: Agnoli A., Cahn J., Lassen N., and Mayeux R. (Eds). Senile dementia. II International symposium (1988), John Libbey Eurotext, Paris 393-397
8. Pizzolato G., Dam M., Borsato N., Saitta B., Da Col C., Perlotto N., et al. (99mTc)-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab 8 Suppl. 1 (1988) S101-S108
9. Leenders K.L., Wolfson L., Gibbs J.M., Wise R.J., Causon R., Jones T., et al. The effects of L Dopa on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease. Brain 108 (1985) 171-191
10. Globus M., Mildworf B., and Melamed E. Cerebral blood flow and cognitive impairment in Parkinson's disease. Neurology 35 (1985) 1135-1139
11. 18F)-fluorodeoxyglucose method. Ann Neurol 15 (1984) 419-424
12. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
13. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
14. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163 (1999) 94-98
15. Minoshima S., Frey K.A., Koeppe R.A., Foster N.L., and Kuhl D.E. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36 (1995) 1238-1248
16. Lees A.J., and Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 106 (1983) 257-270
17. Brown R.G., and Marsden S.D. How common is dementia in Parkinson's disease?. Lancet 2 (1984) 1262-1265
18. Cooper J.A., Sagar H.J., Jordan N., Harvey N.S., and Sullivan E.V. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114 (1991) 2095-2122
19. Taylor A.E., Saint-Cyr J.A., and Lang A.E. Frontal lobe dysfunction in Parkinson's disease. Brain 109 (1986) 845-883
20. Alexander G.E., Delong M.R., and Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 9 (1986) 357-381
21. Middleton F.A., and Strick P.L. A revised neuroanatomy of the fronto-subcortical circuits. In: Lichter D.G., and Cummings J.L. (Eds). Frontal-subcortical circuits in psychiatric and neurological disorders (2000), The Guilford Press, New York 44-58
22. Starkstein S.E., and Kremer J. The disinhibition syndrome and fronto-subcortical circuits. In: Lichter D.G., and Cummings J.L. (Eds). Frontal-subcortical circuits in psychiatric and neurological disorders (2000), The Guilford Press, New York 163-176
23. Starkstein S.E., and Robinson R.G. Depression in neurologic diseases (1993), John Hopkins University Press, Baltimore, MD
24. Taylor A.E., Saint-Cyr J.A., and Lang A.E. Frontal lobe dysfunction in Parkinson's disease. Brain 109 (1986) 845-883
25. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch Neurol 50 (1993) 873-880
26. Richards M., Cote L.J., and Stern Y. Executive function in Parkinson's disease: set-shifting or ser-maintenance?. J Clin Exp Neuropsychol 15 (1993) 266-279
27. Dennis J. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cogn Behav Neurol 16 (2003) 193-210
28. Torack M., and Morris J.C. The association of ventral tegmental area histopahthology with adult dementia. Arch Neurol 45 (1988) 497-501
29. Rinne J.O., Rummukainen J., Paljarvi L., and Rinne U.K. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26 (1989) 47-50
30. 18F]fluoro-L-dopa PET study. Brain 125 (2002) 1358-1365
31. Holthoff-Detto V.A., Kessler J., Herholz K., Bonner H., Pietrzyk U., Wurker M., et al. Functional effects of striatal dysfunction in Parkinson's disease. Arch Neurol 54 (1997) 145-150
32. 18F]fluorodopa positron emission tomographic study. Arch Neurol 57 (2000) 470-475
33. Sawada H., Udaka F., Kameyama M., Seriu N., Nishinaka K., Shindou K., et al. SPECT findings in Parkinson's disease with dementia. J Neurol Neurosurg Psychiatry 55 (1992) 960-963
34. Antonini A., De Notaris R., Benti R., De Gaspari D., and Pezzoli G. Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson's disease. Neurol Sci 22 (2001) 45-46
35. Forno L.S. Pathology of Parkinson's disease. In: Marsden C.D., and Fahn S. (Eds). Movements disorders (1982), Butterworth Scientific, London 25-40
36. Ditter S.M., and Mirra S.S. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 37 (1987) 754-760
37. Jellinger K. Overview of morphological changes in Parkinson's disease. In: Yahr M.D., and Bergmann K.J.B. (Eds). Advances in neurology vol. 45 (1986), Raven Press, New York 1-18
38. Hakim M., and Mathieson G. Dementia in Parkinson's disease: a neuropathologic study. Neurology 29 (1979) 1209-1214
39. Boller F., Mizutani T., Roessmann U., and Gambetti P. Parkinson's disease, dementia, and Alzheimer's disease: clinicopathological correlations. Ann Neurol 7 (1980) 329-335
40. Braak H., and Braak E. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm 2 (1990) 45-47
41. Duyckaerts C., Gaspar P., Costa C., Bonnet A.M., and Hauw J.J. Dementia in Parkinson's disease. Morphometric data. Adv Neurol 60 (1993) 447-455
42. Murayama S., Saito Y., Ishii K., Mitani K., Kanemaru K., Yamanouchi H., et al. Parkinson's disease with dementia-responsible locus for dementia. Rinsho Shinkei 44 (2004) 824-826 [in Japanese]
43. Ince P., Irving D., MacArthur F., and Perry R.H. Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients. J Neurol Sci 106 (1991) 142-152
44. Jendroska K., Lees A.J., Poewe W., and Daniel S.E. Amyloid β-peptide and the dementia of Parkinson's disease. Mov disord 11 (1996) 647-653
45. Perry E.K., Curtis M., Dick D.J., Candy J.M., Atack J.R., Bloxham C.A., et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 43 (1985) 413-421
46. Hardy J., Adolfsson R., Alafuzoff I., Bucht G., Marcusson J., Nyberg P., et al. Transmitter deficit in Alzheimer's disease. Neurochem Int 7 (1985) 545-563
47. Whitehouse P.J., Hedreen J.C., White III C.L., and Price D.L. Basal forebrain neurons in the dementia of Parkinson's disease. Ann Neurol 13 (1983) 243-248
48. Gaspar P., and Gray F. Dementia in idiopathic Parkinson's disease. A neuropathological study of 32 cases. Acta Neuropathol (Berl) 64 (1984) 43-52
49. Nakano I., and Hirano A. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 15 (1984) 415-418
50. Spampinato U., Habert M.O., Mas J.L., Bourdel M.C., Ziegler M., de Recondo J., et al. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 54 (1991) 787-792
51. Liu R.S., Lin K.N., Wang S.J., Shan D.E., Fuh J.L., Yeh S.H., et al. Cognition and [99mTc]HMPAO SPECT in Parkinson's disease. Nucl Med Commun 13 (1992) 744-748
52. Sperling R., Johnson K.A., and Becker J.A. SPECT cerebral perfusion in neurodegenerative disease with dementia. Neurology 43 Suppl. 1 (1993) A406
53. Crystal H.A., Dickson D.W., Lizardi J.E., Davies P., and Wolfson L.I. Antemortem diagnosis of diffuse Lewy body disease. Neurology 40 (1990) 1523-1528
54. Byrne E.J., Lennox G., Lowe J., and Godwin-Austen R.B. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52 (1989) 709-717
55. Perry R.H., Irving D., Blessed G., Perry E.K., and Fairbairn A.F. Clinically and neuropathologically distinct form of dementia in the elderly. Lancet 1 (1989) 116
56. Kosaka K., Yoshimura M., Ikeda K., and Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree-a new disease?. Clin Neuropathol 3 (1984) 185-192
57. Kosaka K. Dementia and neuropathology in Lewy body disease. Adv Neurol 60 (1993) 456-463
58. Guo L., Itaya M., Takanashi M., Mizuno Y., and Mori H. Relationship between Parkinson disease with dementia and dementia with Lewy bodies. Parkinsonism Relat Disord 11 (2005) 305-309
59. Apaydin H., Ahlskog J.E., Parisi J.E., Boeve B.F., and Dickson D.W. Parkinson disease neuropathology. Arch Neurol 59 (2002) 102-112
60. Hurtig H.I., Trojanowski J.Q., Galvin J., Ewbank D., Schmidt M.L., Lee V.M., et al. Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54 (2000) 1916-1921
61. Kovari E., Gold G., Herrmann F.R., Canuto A., Hof P.R., Bouras C., et al. Lewy body densities in the entorhinal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol (Berl) 106 (2003) 83-88
62. Mattila M., Rinne J.O., Helenius H., Dickson D.W., and Roytta M. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathol 100 (2000) 285-290
63. Kasama S., Tachibana H., Kawabata K., and Yoshikawa H. Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging. Dement Geriatr Cogn Disord 19 (2005) 266-275
64. Kamei H., Nakajima T., and Fukuhara N. Statistic rCBF study of extrapyramidal disorders. No To Shinkei 54 (2002) 667-672 [in Japanese]
65. Matsui H., Udaka F., Miyoshi T., Hara N., Tamura A., Oda M., et al. N-isopropyl-p-123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia. Int Med 44 (2005) 1046-1050
66. Abe Y., Kachi T., Kato T., Arahata Y., Yamada T., Washimi Y., et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74 (2003) 419-422
67. Imamura T., Ishii K., Hirono N., Hashimoto M., Tanimukai S., Kazui H., et al. Occipital glucose metabolism in dementia with Lewy bodies with and without Parkinsonism: a study using positron emission tomography. Dement Geriatr Cogn Disord 12 (2001) 194-197
68. Yoshii F., Barker W.W., Chang J.Y., Loewenstein D., Apicella A., Smith D., et al. Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy and cerebrovascular risk factor. J Cerebr Flow Metab 8 (1988) 654-661